First human test for new injection begins

NCT ID NCT07419698

Recruiting now Knowledge-focused Sponsor: Shanghai JMT-Bio Inc. Source: ClinicalTrials.gov ↗

Summary

This is an early safety study for a new injection called JMT206. It will test single, increasing doses in 44 healthy volunteers to see how safe it is and how the body handles it. The main goal is to gather basic safety information, not to treat any disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

BeiJing Cancer Hospital EC
RECRUITING

Beijing, Beijing Municipality, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEALTHY PARTICIPANTS